ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: SA-PO692

Circulating Endothelial Microparticles and Correlation with MEST-C Scores in IgA Nephropathy

Session Information

Category: Pathology and Lab Medicine

  • 1602 Pathology and Lab Medicine: Clinical

Authors

  • Agrawal, Vinita, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India
  • Bharti, Niharika, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India
  • Agarwal, Vikas, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India
  • Prasad, Narayan, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India
Background

Renal endothelial injury or activation can lead to a cascade of pathways that contribute to loss of renal function and fibrosis. Recent reports suggest that endothelial injury may play a role in the pathophysiology of IgAN. Microparticles (MPs) are 0.1 to 1.0 µm membrane vesicles shed from the damaged or activated cell surface following injury. Microparticles derived from endothelial cells are called endothelial microparticles (EMPs) and play an important role in promoting endothelial dysfunction. They can act as biomarkers of disease state and progression. The aim of this study was to study the presence and quantify the levels of circulating MPs of endothelial origin in plasma from patients with IgAN and healthy controls.

Methods

25 biopsy-proven IgA nephropathy (Mean age=32.8±8.2 years) and 25 healthy controls (Mean age=30±7.6 years) were recruited in this study. Platelet-poor-plasma from citrated blood was isolated and centrifuged at 20,000g (90 min) at 4 degree C. EMPs were analyzed by Flow cytometry using EMP specific antibodies for antiCD31-FITC and antiCD146-PE. All quantification related to size and number was done by using cell count beads of known concentration. The levels of circulating endothelial MPs were correlated with renal biopsy features of the Oxford classification (MEST-C scores). The study was reviewed and approved by the Institutional Ethics Committee.

Results

There are significantly higher levels of total circulating MPs and EMPs in IgAN compared to healthy controls (p<0.05). EMPs levels were increased in patients with hypertension and correlated with presence of mesangial and endocapillary hypercellularity (p<0.05) on renal biopsy (Table 1).

Conclusion

IgAN shows evidence of significant endothelial injury/dysfunction. A non-invasive method of detection of levels of circulating EMPs can predict the severity of glomerular injury and may be a simple method useful for monitoring endothelial injury in IgAN.

Table 1. Correlation of Circulating Endothelial Microparticle (EMP) counts with MEST-C scores in IgAN
MEST-C score on Renal Biopsy
MPs/μl plasma Circulating EMPs/μl plasma (CD31+/CD146+) P value
Mesangial Proliferation
M0
M1


105±12
187±107
21±2.8
44±27
0.04
Endocapillary Proliferation
E0
E1
141±49
242±141
31±14
60±33
0.001
Segmental sclerosis
S0
S1
168±93.3
188±116
40±26
43±26
0.614
Tubular Atrophy
Absent
Present

126±34
156±89
37±13
44±29
0.433
Crescent
Absent
Present
164±82
200±140
39±26
45±27
0.512

Funding

  • Government Support - Non-U.S.